Skip to Content

BMS 100 mg 3623 (Reyataz 100 mg)

Generic Name: atazanavir

Pill imprint BMS 100 mg 3623 has been identified as Reyataz 100 mg.

Reyataz is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 100 mg is not a controlled substance under the Controlled Substance Act (CSA).

Reyataz 100 mg BMS 100 mg 3623
Reyataz 100 mg BMS 100 mg 3623
Discount Card Promo
Reyataz
Generic Name:
atazanavir
Imprint:
BMS 100 mg 3623
Strength:
100 mg
Color:
Blue & White
Size:
18.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Protease inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Bristol-Myers Squibb
National Drug Code (NDC):
00003-3623
Inactive Ingredients:
crospovidone
lactose monohydrate
magnesium stearate
gelatin
FD&C Blue No. 2
titanium dioxide
ferric oxide red
ferric oxide yellow
isopropyl alcohol
ammonia
propylene glycol
butyl alcohol
alcohol
ferrosoferric oxide
shellac

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide